🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease

RecruitingNAAges 50 Years - 80 YearsAllShanghai General Hospital, Shanghai Jiao Tong Uni…
NCT06002581 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

At present, no drug therapy has been proven to delay the progression of Parkinson's disease (PD). rTMS, as a non-invasive neuromodulation method, can regulate Slow-wave sleep (SWS). SWS is recognized closely related to neurodegeneration. However, there has been no clinical studies on if rTMS could delay the progression of PD by regulating SWS. The main purpose of this study is to explore the changes of SWS in non-rapid eye movement (NREM) sleep period in PD patients by using rTMS, and the relationship with potential improvements of SWS and motor symptom delay. The study aims to find a potential new treatment strategy to delay the neurodegenerative process in PD patients by modulating SWS by rTMS.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Meet the clinically definite or clinically probable PD according to the MDS 2015 version. 2. Chinese Han population (three generations), age greater than or equal to 50 years old, less than or equal to 80 years old, male or female. 3. Hoehn-Yahr stages 1-4. 4. The dose of levodopa drug therapy was stable three weeks before enrollment and during the follow-up period. 5. Right-handed. 6. The patient signed a written informed consent. Exclusion Criteria: 1. Any form of Parkinsonism other than primary PD. 2. Those who have received neurosurgical intervention or stereotaxic brain surgery for PD, or have previously received TMS treatment. 3. Cognitive dysfunction (MMSE ≤ 24 points) or those who cannot cooperate with the scale score. 4. Persons with mental disabilities. 5. Pregnant women. 6. There are contraindications for rTMS treatment. 7. There are contraindications for MRI examination. 8. Baseline PSG suggests other sleep disorders such as moderate to severe OSAS; BMI\>=30. 9. Patients who are addicted to alcohol, taking SSRIs, TCAs, sedative hypnotics, histamine antagonists and other drugs and food that may affect NREM and REM sleep structure. 10. Those who are unwilling to participate in the study or unable to sign the informed consent form; and other circumstances that the researcher considers inappropriate to participate in the study. \-
💊

What it tests

  • rTMS real stimulation stage1
  • rTMS shame stimulation stage1
  • rTMS real stimulation stage 2
📍

Where

1 site
Shanghai Jiao Tong University School of Medicine
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy